About Drug Development Solutions
We help develop new medicines and products to improve the quality of life
Drug Development Solutions is a contract research organisation (CRO) offering GLP and GCP bioanalysis of small molecules, large proteins for pharmacokinetics, biomarkers and immunogenicity. We also provide cGMP analytical sciences research and testing services, consultancy and quality control solutions to support Chemistry Manufacturing and Control (CMC) requirements at all stages of the drug development pipeline from discover through preclinical and clinical development to commercial manufacture.
Our Cambridge (Fordham) site is one of the largest bioanalytical centres in the world. The site employs around 380 scientists operating from 8,000m2 purpose-built, state-of-the-art analytical labs.
Drug Development Solutions is part of LGC Group, an international life sciences measurement and testing company, building leading positions in sustainably growing markets, with expertise in regulation, accreditation and standard setting. LGC Group provides reference materials, genomics solutions and analytical testing products and services, based on its innovations and own intellectual property.